|
NEO1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.13629999995724E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.022290E-03 |
| Normal-vs-Stage2 |
3.9953000000037E-05 |
| Normal-vs-Stage3 |
1.138230E-03 |
| Normal-vs-Stage4 |
3.681700E-03 |
| Stage1-vs-Stage2 |
2.823500E-02 |
| Stage1-vs-Stage3 |
2.995800E-01 |
| Stage1-vs-Stage4 |
2.533800E-01 |
| Stage2-vs-Stage3 |
3.039200E-01 |
| Stage2-vs-Stage4 |
5.482800E-01 |
| Stage3-vs-Stage4 |
7.687800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.40849999999515E-05 |
| Normal-vs-AfricanAmerican |
1.94311999999197E-05 |
| Normal-vs-Asian |
5.751600E-01 |
| Caucasian-vs-AfricanAmerican |
9.042300E-02 |
| Caucasian-vs-Asian |
6.968400E-01 |
| AfricanAmerican-vs-Asian |
2.664000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.07259999665632E-08 |
| Normal-vs-Female |
1.160790E-01 |
| Male-vs-Female |
2.034700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.963000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.374600E-04 |
| Normal-vs-Age(61-80Yrs) |
4.12640000000408E-05 |
| Normal-vs-Age(81-100Yrs) |
9.979000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.788400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.114000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.396400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.152600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.104000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.841900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.446800E-01 |
| Normal-vs-Grade 2 |
2.976300E-03 |
| Normal-vs-Grade 3 |
5.91679999999428E-05 |
| Normal-vs-Grade 4 |
3.557800E-04 |
| Grade 1-vs-Grade 2 |
5.629200E-01 |
| Grade 1-vs-Grade 3 |
1.349760E-01 |
| Grade 1-vs-Grade 4 |
3.723800E-02 |
| Grade 2-vs-Grade 3 |
1.930570E-01 |
| Grade 2-vs-Grade 4 |
4.937500E-02 |
| Grade 3-vs-Grade 4 |
2.352000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.535200E-01 |
| Normal-vs-ccB subtype |
4.32430000030237E-07 |
| ccA subtype-vs-ccB subtype |
4.05329999997317E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.658140E-03 |
| Normal-vs-N1 |
4.663200E-01 |
| N0-vs-N1 |
9.476000E-01 |
|
|
